Pharmaceutical Technology on MSN15h
Lundbeck acquires all outstanding shares of Longboard Pharma
Lundbeck has completed the acquisition of all outstanding shares of Longboard Pharmaceuticals, to bolster the neuro-rare disease sector.
Hosted on MSN1mon
Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company
Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.
Longboard Pharmaceuticals (NASDAQ:LBPH) Acquired by H. Lundbeck A/S; SEC Filing Reveals Key Details
On December 2, 2024, Longboard Pharmaceuticals, Inc., a Delaware corporation (NASDAQ: LBPH), was officially acquired by H. Lundbeck A/S, a Danish aktieselskab, as per an Agreement and Plan of Merger ...
U.S. News & World Report3y
Longboard Pharmaceuticals Inc
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on ...
CNN2y
Longboard Pharmaceuticals, Inc.
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on ...
Wall Street Journal2y
Longboard Pharmaceuticals Inc.
Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...